Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate controlled release vs immediate release in dyslipidemia
NCT04079530Phase 2Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemafibrate in dyslipidemia, sponsored by Kowa Company, Ltd.. Started Sep 2019; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT04079530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079530.